Physician profile
Derick Haggard
NPI 1386667632
$1,655.34
in general payments reported to CMS, 2019-2025
10 companies · $666 in 2025
The $666 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137 · 2021: $18.94 · 2022: $22.90 · 2023: $170 · 2024: $641 · 2025: $666.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $753 · Food and Beverage: $687 · Education: $37.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $752.87 |
| Food and Beverage | $686.57 |
| Education | $37.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,350.55 | 2019-2025 | |
| Heron Therapeutics, INC. | $122.79 | 2023 | Zynrelef |
| Ethicon US, LLC | $37.22 | 2024 | Stratafix |
| Boston Scientific Corporation | $31.41 | 2023 | Exalt Model D, Spyscope Ds |
| Pfizer INC. | $22.90 | 2022 | |
| Elucent Medical | $22.47 | 2024 | |
| Endomagnetics LTD | $18.94 | 2021 | |
| Biocomposites INC | $17.25 | 2025 | Stimulan |
| Astellas Pharma US INC | $16.11 | 2019 | |
| Kci USA, INC. | $15.70 | 2023 | Prevena, Abthera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derick Haggard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.